3B21.1

ICD-11 MMS 2026-01

Haemorrhage due to factor Xa inhibitor

Description

A disease caused by factor Xa inhibitor that affects normal coagulation of the blood. This disease is characterised by inability of the blood to coagulate leading to bleeding. Confirmation is by identification of factor Xa inhibitor in a blood sample.

Index terms

  • Haemorrhage due to factor Xa inhibitor

Exclusions from above levels

  • QC48.0 – long-term use of anticoagulants without haemorrhage
  • KA8F.0 – vitamin K deficiency of newborn
  • JA43.3 – Postpartum coagulation defects
Show allHide
  • 04 – Diseases of the immune system
  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth or the puerperium
  • 19 – Certain conditions originating in the perinatal period
  • 20 – Congenital malformations, deformations or chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
  • JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Sibling codes

  • 3B21.0 – Haemorrhage due to thrombin inhibitor other than heparin
  • 3B21.Y – Haemorrhagic disorder due to other specified circulating anticoagulants or coagulation factors
  • 3B21.Z – Haemorrhagic disorder due to unspecified circulating anticoagulants or coagulation factors

Foundation entity

Haemorrhage due to factor Xa inhibitor – http://id.who.int/icd/entity/171766827

Part of: 3B21: Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors › 03: Diseases of the blood or blood-forming organs